NCT00195091 Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer Status TERMINATED Phase PHASE2
NCT00153920 Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00142571 Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma Status COMPLETED Phase PHASE3
NCT00142519 Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain Status COMPLETED Phase PHASE2
NCT00142506 Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer Status COMPLETED Phase PHASE3
NCT00142493 Effect of Affective Content on Drug Induced Amnesia of Episodic Memory Status COMPLETED Phase PHASE1
NCT00140868 Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery Status COMPLETED Phase PHASE3
NCT00138112 Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation Status COMPLETED Phase PHASE3
NCT00136682 Patient-Controlled Epidural Analgesia (PCEA) for Patients Who Have Had Major Open Gynecologic Surgery Status COMPLETED Phase PHASE3
NCT00132704 An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation Status COMPLETED Phase N/A
NCT00131898 A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma Status COMPLETED Phase PHASE3
NCT00130780 Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC Status COMPLETED Phase PHASE2
NCT00119301 Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma Status COMPLETED Phase PHASE1
NCT00107289 Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma Status RECRUITING Phase PHASE2
NCT00104845 Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma Status COMPLETED Phase PHASE1